| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/10/2003 | CA2438330A1 A method for the early detection of cancer |
| 04/10/2003 | CA2425363A1 Benzimidazole compounds, process for producing the same and use thereof |
| 04/09/2003 | EP1300424A1 Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use |
| 04/09/2003 | EP1300398A1 Propane-1,3-dione derivatives |
| 04/09/2003 | EP1300159A1 Remedies for cancer |
| 04/09/2003 | EP1300148A2 Use of bismuth subgallate in inhibition of production of nitric oxide synthase |
| 04/09/2003 | EP1300146A1 Pharmaceutical composition for the treatment of animal mammary tumors |
| 04/09/2003 | EP1299727A2 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 04/09/2003 | EP1299551A2 7677, a novel human atpase family member and uses therefor |
| 04/09/2003 | EP1299548A1 Novel therapeutic molecular variants and uses thereof |
| 04/09/2003 | EP1299546A2 Aminoacyl trna synthetases |
| 04/09/2003 | EP1299545A2 Drug metabolizing enzymes |
| 04/09/2003 | EP1299538A2 Secreted proteins |
| 04/09/2003 | EP1299536A1 Novel alpha-catenin expressed in heart and testis |
| 04/09/2003 | EP1299534A2 Grf2-binding proteins and applications thereof |
| 04/09/2003 | EP1299533A2 Antisense oligonucleotides to inhibit angiogenesis and/or metastasis |
| 04/09/2003 | EP1299529A2 Conserved diaphanous-related formin autoregulatory domain (dad) |
| 04/09/2003 | EP1299524A1 Human myeloma cell line |
| 04/09/2003 | EP1299522A2 Alteration of cell membrane |
| 04/09/2003 | EP1299421A2 Antibodies to human mcp-1 |
| 04/09/2003 | EP1299419A2 Bispecific immunoglobulin-like antigen binding proteins and method of production |
| 04/09/2003 | EP1299417A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 04/09/2003 | EP1299415A1 Chemokine receptor modulators, production and use |
| 04/09/2003 | EP1299412A2 Protein modification and maintenance molecules |
| 04/09/2003 | EP1299410A2 GFR alpha1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 04/09/2003 | EP1299406A1 Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same |
| 04/09/2003 | EP1299388A1 Variolin derivatives as anti-cancer agents |
| 04/09/2003 | EP1299385A2 Fused cyclic modulators of nuclear hormone receptor function |
| 04/09/2003 | EP1299381A1 Substituted quinazoline derivatives and their use as inhibitors |
| 04/09/2003 | EP1299365A1 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 04/09/2003 | EP1299364A1 Benzodiazepines as inhibitors of hpv e1 helicase |
| 04/09/2003 | EP1299363A1 Polymorphic forms/hydrates of n- 4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochloride |
| 04/09/2003 | EP1299355A2 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors |
| 04/09/2003 | EP1299351A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives |
| 04/09/2003 | EP1299350A1 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness |
| 04/09/2003 | EP1299128A2 Cold anti-cd20 antibody/radiolabeled anti-cd22 antibody combination |
| 04/09/2003 | EP1299113A2 Use of the heat shock protein gp96 |
| 04/09/2003 | EP1299110A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites |
| 04/09/2003 | EP1299103A1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 04/09/2003 | EP1299097A1 Decreasing the intracellular level of beta-catenin by administering hydroxymatairesinol |
| 04/09/2003 | EP1299094A2 Selective androgen receptor modulators and methods for their identification, design and use |
| 04/09/2003 | EP1299093A2 Combinations of bisphosphonates, estrogenic agents and optionally estrogens |
| 04/09/2003 | EP1299092A2 Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel |
| 04/09/2003 | EP1299087A1 Microspheres and adjuvants for dna vaccine delivery |
| 04/09/2003 | EP1299085A2 Improved liposomal camptothecins and uses thereof |
| 04/09/2003 | EP1299084A2 Liposomal antineoplastic drugs and uses thereof |
| 04/09/2003 | EP1299039A1 Use of a liquid medicament in surgical high pressure liquid jet devices |
| 04/09/2003 | EP1299032A1 DNA encoding human serine protease D-G |
| 04/09/2003 | EP1220844B1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 04/09/2003 | EP1140885B1 Method for high yield extraction of paclitaxel from paclitaxel-containing material |
| 04/09/2003 | EP0946165B1 Integrin antagonists |
| 04/09/2003 | EP0928200B1 Therapeutic combinations of rar antagonists and rxr agonists |
| 04/09/2003 | EP0906303B1 Ring-fused dihydropyranes, process for the preparation and use thereof |
| 04/09/2003 | EP0874808B1 Biphenyl hydroxamate inhibitors of matrix metalloproteinases |
| 04/09/2003 | EP0873123B1 Inhibitors of protein isoprenyl transferases |
| 04/09/2003 | EP0850224B1 Radiation-activated cytotoxin therapy |
| 04/09/2003 | EP0793492B1 Use of sclareolide for treating disorders characterised by excessive cell proliferation |
| 04/09/2003 | EP0784685B1 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 04/09/2003 | EP0778774B1 New use of prostaglandins |
| 04/09/2003 | EP0768898B1 Cascade-polymer complexes and methods of producing the same |
| 04/09/2003 | EP0675956B1 New protein from urine named component b |
| 04/09/2003 | CN1409724A 雌二醇轭合物和其用途 Estradiol conjugates and uses thereof |
| 04/09/2003 | CN1409715A Cyclopenteneone derivatives |
| 04/09/2003 | CN1409714A Pentacycle taxane compounds |
| 04/09/2003 | CN1409712A Pyrrolo [2,3-d] pyrimidine compounds |
| 04/09/2003 | CN1409709A Substituted bisindolylmaleimides for inhibition of cell proliferation |
| 04/09/2003 | CN1409708A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 04/09/2003 | CN1409704A Heterocycle derivatives and drugs |
| 04/09/2003 | CN1409703A 4-aminopiperidine derivatives and their use as medicine |
| 04/09/2003 | CN1408880A Detecting and trapping receptor 3 monoclonal antibody, hybrid tumor for producing said antibody and its use |
| 04/09/2003 | CN1408438A Gene vaccine based on macrophage colony stimulating factor recepter and its use |
| 04/09/2003 | CN1408437A Microcapsule adrenomedullary cell for curing malignant, tumor pain and its preparing method |
| 04/09/2003 | CN1408431A Gene engineering medicine for curing diseases relative to vascularization |
| 04/09/2003 | CN1408430A Method for producing anti-cancer medicine from silkworm |
| 04/09/2003 | CN1408426A Medicinal tea for preventing and curing tumor and preventing AIDs |
| 04/09/2003 | CN1408420A Capsule for preventing and treating cancer |
| 04/09/2003 | CN1408419A Oral liquid for preventing and treating cancer |
| 04/09/2003 | CN1408417A Method for preparing anti-cancer traditional Chinese medicine containing Mingri leaf |
| 04/09/2003 | CN1408404A Cancer curing medicine |
| 04/09/2003 | CN1408401A Cherry extract and its extracting method |
| 04/09/2003 | CN1408387A Tea essence compound medicine and its preparing method |
| 04/09/2003 | CN1408384A Pure traditional Chinese medicine preparation for curing lung cancer |
| 04/09/2003 | CN1408383A Pure traditional Chinese medicine preparation for curing gastroinstestinal cancer and preparing method |
| 04/09/2003 | CN1408365A Local applied medicine composition for curing subcutaneous tumor |
| 04/09/2003 | CN1408353A Use of tanshin polyphenolic acid B in preparing tumor curing medicine |
| 04/09/2003 | CN1408347A High nurity elemene anti-cancer medicine and its preparing method |
| 04/09/2003 | CN1408346A Elemene aerosol and its preparing method |
| 04/09/2003 | CN1408345A B-elemene aerosol and its preparing method |
| 04/09/2003 | CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds |
| 04/09/2003 | CN1105101C Beta-sultonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 04/09/2003 | CN1104900C Use of 8,9-dehydroestrone as anti-oxidant |
| 04/08/2003 | WO2002034715A1 Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists |
| 04/08/2003 | US6545182 Methods and compositions for modulating alpha adrenergic receptor activity |
| 04/08/2003 | US6545150 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
| 04/08/2003 | US6545138 Nucleic acid complex |
| 04/08/2003 | US6545125 Reaction product containing paclitaxel; anticancer agent |
| 04/08/2003 | US6545124 Antiproliferative agents |
| 04/08/2003 | US6545049 E.g., (2E, 4E, 6E)-7-(3,5-diisopropyl-2-n-heptyloxyphenyl)-3-methylocta-2,4,6-trienoic acid, esters or amides thereof |
| 04/08/2003 | US6545048 Compositions and methods of treating cancer using compositions comprising an inhibitor or endothelin receptor activity |
| 04/08/2003 | US6545038 Heterocyclic metalloprotease inhibitors |